Detalles de la búsqueda
1.
Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array-CGH interpretation.
Genes Chromosomes Cancer
; 63(3): e23229, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38481055
2.
Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trial.
Gynecol Oncol
; 168: 62-67, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401942
3.
PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients.
Gynecol Oncol
; 173: 98-105, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37105063
4.
Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
Gynecol Oncol
; 174: 190-199, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210929
5.
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Gynecol Oncol
; 170: 186-194, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36706645
6.
Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse.
Int J Gynecol Cancer
; 33(4): 577-584, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36631150
7.
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort.
Gynecol Oncol
; 167(1): 11-21, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970603
8.
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Gynecol Oncol
; 164(2): 254-264, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34952708
9.
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
Gynecol Oncol
; 165(1): 30-39, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123771
10.
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
Gynecol Oncol
; 166(3): 389-396, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35902297
11.
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Gynecol Oncol
; 164(1): 18-26, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34696892
12.
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer.
Int J Gynecol Cancer
; 2022 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858711
13.
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(12): 1721-1731, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715071
14.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(5): 620-631, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743851
15.
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.
Breast Cancer Res
; 23(1): 79, 2021 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34344426
16.
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
Int J Cancer
; 148(8): 1895-1909, 2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33368296
17.
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 379(26): 2495-2505, 2018 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30345884
18.
"Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".
BMC Cancer
; 21(1): 1147, 2021 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34702204
19.
Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial.
Gynecol Oncol
; 163(1): 41-49, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34353615
20.
Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.
Gynecol Oncol
; 163(1): 64-71, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34294414